Durable efficacy of selpercatinib in patients with RET fusion plus solid tumors, with a focus on GI tumors: LIBRETTO-001 Meeting Abstract


Authors: Subbiah, V.; Drilon, A. E.; Sukrithan, V.; Spira, A. I.; Robinson, B.; Deschler-Baier, B.; Barker, S.; Lin, Y.; Szymczak, S.; Ohe, Y.
Abstract Title: Durable efficacy of selpercatinib in patients with RET fusion plus solid tumors, with a focus on GI tumors: LIBRETTO-001
Meeting Title: 2024 ASCO Gastrointestinal Cancers Symposium
Keywords: 283-324; 613-135-244-3829-325; 261-492-5651-9270-5657; 283-237-255; 38092-30911; 3282-206-4957-6709-11793; 261-492-5651-5481; 261-492-5651-9270-5652; 38092-25165
Journal Title: Journal of Clinical Oncology
Volume: 42
Issue: 3 Suppl.
Meeting Dates: 2024 Jan 18-20
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2024-01-20
Language: English
ACCESSION: WOS:001266680500558
DOI: 10.1200/JCO.2024.42.3_suppl.746
PROVIDER: wos
Notes: Meeting Abstract: 746 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon